Edition:
India

Brainstorm Cell Therapeutics Inc (BCLI.OQ)

BCLI.OQ on NASDAQ Stock Exchange Capital Market

3.79USD
18 Apr 2019
Change (% chg)

-- (--)
Prev Close
$3.79
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
15,773
52-wk High
$5.34
52-wk Low
$2.95

About

Brainstorm Cell Therapeutics Inc. is a biotechnology company. The Company is engaged in developing adult stem cell therapies for debilitating neurodegenerative disorders, such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Multiple Sclerosis (MS) and Parkinson's disease (PD), among others. Its... (more)

Overall

Beta: 1.30
Market Cap(Mil.): $81.45
Shares Outstanding(Mil.): 21.49
Dividend: --
Yield (%): --

Financials

Earnings vs. Estimates